<?xml version="1.0" encoding="utf-8" standalone="yes"?><rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom"><channel><title>Topcon-Healthcare on Bioecon</title><link>https://en.bioecon.ru/companies/topcon-healthcare/</link><description>Recent content in Topcon-Healthcare on Bioecon</description><generator>Hugo</generator><language>en-US</language><lastBuildDate>Mon, 20 Jul 2026 20:28:27 +0700</lastBuildDate><atom:link href="https://en.bioecon.ru/companies/topcon-healthcare/index.xml" rel="self" type="application/rss+xml"/><item><title>AI optical coherence tomography screening</title><link>https://en.bioecon.ru/technology/ai-optical-coherence-tomography-screening/</link><pubDate>Mon, 20 Jul 2026 00:00:00 +0000</pubDate><guid>https://en.bioecon.ru/technology/ai-optical-coherence-tomography-screening/</guid><description>AI-assisted optical coherence tomography and fundus imaging for broad-disease eye screening — diabetic retinopathy, age-related macular degeneration and glaucoma — spanning home-use monitoring devices, multimodal clinic platforms and autonomous AI diagnostic software: Notal Vision and iHealthScreen in the US, Topcon Healthcare (Japan), RetinAI in Switzerland (acquired by EssilorLuxottica), and Airdoc in China.</description></item></channel></rss>